Shady Sayed representing the Buchholz Lab at the 21st International AEK Cancer Congress in Kassel

Shady Sayed’s abstract has been selected as an abstract short talk at the 21st International AEK Cancer Congress in Kassel from February 15 to 17, 2023. The abstract titled “Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base … Continue reading

Posted in Uncategorized | Comments Off

Deutscher Studienpreis award ceremony for Felix Lansing in Berlin

For this groundbreaking contribution to finding treatment for more then 8,000 diseases  that can be traced back to gene defect, Felix Lansing was awarded second place in the Deutscher Studienpreis of the Körber Foundation. The award ceremony took place in … Continue reading

Posted in Uncategorized | Comments Off

Felix Lansing awarded German Study Prize in Natural and Technical Sciences

Dr Felix Lansing has made a groundbreaking contribution to cell and gene therapy, for which he was awarded 2nd place in the Deutscher Studienpreis by the Körber Foundation. “In my dissertation,” outlines Dr Lansing, “I developed a new molecular scalpel … Continue reading

Posted in Uncategorized | Comments Off

New start-up company RecTech GmbH founded

RecTech GmbH is a brand new start-up focused on developing designer recombinases for precision genome editing. Supported by the BMBF GO-Bio programme, the lab of Frank Buchholz founded the company to translate its scientific findings into a translational pipeline. @RecTech_Dresden … Continue reading

Posted in Uncategorized | Comments Off

Designer recombinase can precisely correct disease-relevant gene defect in severe form of hemophilia A

The research team led by Prof. Frank Buchholz at the Carl Gustav Carus Medical Faculty of the Technical University of Dresden has succeeded in developing an enzyme that can efficiently and specifically correct a gene mutation in the Factor VIII … Continue reading

Posted in Uncategorized | Comments Off